Advertisement

Integration of Modern Data in WHO Categorization of Lymphosarcomas. Its Value for Prognosis Prediction and Therapeutic Adaptation to Prognosis

  • G. Mathé
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 64)

Abstract

Many classifications of hematosarcomas or malignant non-Hodgkin’s lymphosarcomas have been proposed [3, 9, 16, 17, 23, 20, 29]. Some are still used, mainly that of Rappaport [29], which were conceived before the establishment of the concept of lymphocyte transformation by antigen(s) into large pyroninophilic cells (Fig. 1), which were confused with “histiocytes” before this concept and have been called immunoblasts by DAMESHEK [7]. The recent availability of immune and/or cytochemical markers (Fig 2) able to recognize T- and B- and so-called null lymphocytes (Table 1) [6,13, 31, 36, 38] have not only subtracted from the so-called
Table I.

T- and B- immune markers

histiocytic tumors, the immunoblastic lymphosarcoma [22], but also mycosis fungoides which have been shown to be a T-lymphosarcoma [18]. Hence, the field of histiocytic sarcomas has been restricted and may be still further restricted if not suppressed in the future when we are able to identify the tumors composed of reticulum and/or dentritic cells, such as the cells recently studied by Steinman et. al. [33,34,35]. For this reason, the WHO Reference Center for the Classification of Neoplasias of Hematopoietic and Lymphoid tissues [23] has decided to use the term reticulosarcoma to designate the sarcomas of so-called mononuclear phagocytes, according to a WHO monograph [37] because it is historical [26] and because there is no proof that the cells which constitute this tumor in a strict sense are not reticulum cells and/or dentritic cells.

Keywords

Chronic Myeloid Leukemia Mycosis Fungoides Modern Data Acute Lymphoid Leukemia Histiocytic Sarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Belpomme, D., Lelarge, N., Mathé G., Davies, A. J. S.: Etiological, clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukaemias and non-Hodgkin’s lymphomas. In: Immunological Diagnosis of Leukemias and Lymphomas. Thierfelder, S., Roft, H., Thiel, E. (eds) Heidelberg-New York: Springer-Verlag 1977a, p. 33.CrossRefGoogle Scholar
  2. 2.
    Belpomme, D., Mathé, G., Davies, A. J. S.: Clinical significance and prognostic value of the T-B immunological classification of human primary acute lymphoid leukaemias. Lancet 1977b I, 555.CrossRefGoogle Scholar
  3. 3.
    Bennett, M. H., Farrer-Brown, G., Henry, K., Jeliffe, A. M.: Classification of non-Hodgkin’s lymphomas. Lancet 1974 I, 1295.Google Scholar
  4. 4.
    Billing, R., Rafizadeh, B., Drew, I., Hartman, G., Gale, R., Terasaki, P.: Human B-lymphocyte antigen expressed by lymphocytic and myelocytic leukaemia cells. J. Exp. Med. 144 ,167 (1976).PubMedCrossRefGoogle Scholar
  5. 5.
    Binet, J. L., Mathé, G.: Optical and electron microscopy studies of the immunological competent cells during the reaction of the graft versus host. Ann. NY. Acad. Sci. 99 ,426 (1962).PubMedCrossRefGoogle Scholar
  6. 6.
    Catowsky, D., Galetto, J., Okos, A., Miliani, E., Galton, D. A. G.: Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J. Clin. Pathol. 27 ,767(1974).CrossRefGoogle Scholar
  7. 7.
    Dameshek, W.: “Immunoblasts” and “Immunocytes”; an attempt at a functional nomenclature. Blood 27, 243(1963).Google Scholar
  8. 8.
    Dantchev, D., Belpomme, D.: Critical study of the mononuclear leukocyte morphology based on scanning electron microscopy in normal subjects and in patients with lymphoid or monocytoid proliferative disorders. Comparison with the T, B or null cell membrane phenotypes. Biomedicine 26 ,202(1976).Google Scholar
  9. 9.
    Dorfman; R. F.: the non-Hodgkin’s lymphomas. In: The Reticulo Endothelial System. Rebuck, J. W., Berard, C. W., Abell, M. R. (eds) Baltimore: Williams and Wilkins 1975, p. 262.Google Scholar
  10. 10.
    Greaves, M. F., Brown, G., Rapson, N., Lister, T. A. Antisera to acute lymphoblastic leukaemia cells. Clin. Immunol. Immunopathol. 4 ,67 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    Hausen, H. zur: Oncogenic herpes virus. Biochim. Biophys. Acta. 417 ,25 (1975).PubMedGoogle Scholar
  12. 12.
    Janossy, G., Roberts, M., Greaves, M. F.: Target cell in chronic myeloid leukemia and its relationship to acute lymphoid leukemia. Lancet 1976 I, 1058.CrossRefGoogle Scholar
  13. 13.
    Jondal, M., Holm, G., Wigzell, H.: A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J. Exp. Med. 136 ,207 (1972).PubMedCrossRefGoogle Scholar
  14. 14.
    Kadin, M. E., Garratty, E., Scalapino, J.: Detection of a new B-membrane antigen in Hodgkin’s disease and non-Hodgkin’s lymphomas. Proc. Assoc. Cancer Res. 18 ,29 (abstr. 113) (1977).Google Scholar
  15. 15.
    Kersey, J., Sabad, A., Gajl-Peczalska, K., Hallgren, H., Yunis, E., Nesbit, M.: Acute lymphoblastic leukemia cells with markers of T (thymus derived) lymphocytes. Science 182 ,1355 (1973).PubMedCrossRefGoogle Scholar
  16. 16.
    Lennert, K., Mohri, N., Stein, H., Kaiserling, E. The histopathology of malignant lymphoma. Br. J. Haematol. 31 (suppl.), 193 (1975).CrossRefGoogle Scholar
  17. 17.
    Luckes, R. J., Collins, R. D.: A functional classification of malignant lymphomas. In: The ReticuloEndothelial System. Rebuck, J. W., Berard, C. W., Abell, M. R. (eds) Baltimore: Williams and Wilkins 1975, p. 213.Google Scholar
  18. 18.
    Lutzner, M., Edelson, R., Schein, P., Green, I., Kirkpatrick, C., Ahmed, A.: Cutaneous T-cell lymphomas: the Sezary syndrome, mycosis fungoides and related disorders. Ann. Intern. Med. 83 ,534 (1975).PubMedGoogle Scholar
  19. 19.
    Mann, R. B., Jaffe, E. S., Braylan, R. C., Nanba, K., Frank, M. M., Ziegler, J. L., Berard, C. W.: Non-endemic Burkitt’s lymphoma. A B-cell tumor related to germinal centers. N. Engl. J. Med. 295 ,685 (1976).PubMedCrossRefGoogle Scholar
  20. 20.
    Mathé, G., Seman, G.: Aspects Histologiques et Cytologiques des Leucémies et Hématosarcomes. Maloine: Paris 1963.Google Scholar
  21. 21.
    Mathé, G., Pouillart, P., Sterescu, M., Amiel, J. L., Schwarzenberg, L., Schneider, M., Hayat, M., De Vassal, F., Jasmin, C., Lafleur, M.: Subdivision of clinical varieties of acute leukemia. Correlation with prognosis and cure expectancy. Eur. J. Clin. Biol. Res. 16 ,554 (1971).Google Scholar
  22. 22.
    MathÉ, G., Belpomme, D., Dantchev, D., Khalil, A. M., Afifi, A. M., Taleb, N., Pouillart, P., Schwarzenberg, L., Hayat, M., De Vassal, F., Jasmin, C., Misset, J. L., Musset, M.: Immunoblastic lymphosarcoma. A cytological and clinical entity? Biomedicine 22 ,473 (1975).PubMedGoogle Scholar
  23. 23.
    MathÉ, G., Rappaport, H., O’Conor, G. T., Torloni, H.: Histological and Cytological Typing of Neoplastic Diseases of Haematopoietic and Lymphoid Tissues. World Health Organization: Geneva 1976.Google Scholar
  24. 24.
    Misset, J. L., MathÉ, G., Tubiana, M., Caillou, B., Pouillart, P., Gil, M., Tentas, C., Delgado, M.: Preliminary results of chemoradiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation. In: Lymphoid Neoplasias. MathÉ, G., Seligmann, M., Tubiana, M. (eds) Heidelberg-New York: Springer-Verlag, 1978 (in press).Google Scholar
  25. 25.
    Nathwani, B. N., Kim, H., Rappaport, H.: Malignant lymphoma, lymphoblastic. Cancer 38 ,964 (1976).PubMedCrossRefGoogle Scholar
  26. 26.
    Oberling, G.: Les réticulosarcomes et les réticulo-endothélio-sarcomes de la moelle osseuse (sarcome d’Ewing). Bull. Cancer (Paris) 17 ,259 (1928).Google Scholar
  27. 27.
    O’Conor, G. T. Histopathological classification of Burkitt’s tumour. Bull. W.H.O. 40 ,601 (1969).Google Scholar
  28. 28.
    Pazmino, N. H., MacEwan, R. N., Ihle, J. N.: Terminal transferases: enzyme marker for a specific prothymocyte cell populations. Proc. Am. Assoc. Cancer Res. 18 ,81 (abstr. 332) (1977).Google Scholar
  29. 29.
    Rappaport, H.: Tumors of the Hematopoietic Systems. In Atlas of Tumor Pathology. Section 3, Fasc. 8. Armed Forces Institute Pathology: Washington 1966.Google Scholar
  30. 30.
    Schlossmann, S. S.: personal communication.Google Scholar
  31. 31.
    Seligmann, M., Preud’homme J. L., Brouet, J. C.: B and T cell markers in human proliferative blood diseases and primary immuno-deficiencies with special references to membrane bound immunoglobulins. Transplant. Rev. 16 ,85 (1973).PubMedGoogle Scholar
  32. 32.
    Sen, L., Borella, L.: Clinical importance of lymphoblasts with T markers in childhood acute leukaemia, N. Engl. J. Med. 292 ,828 (1975).CrossRefGoogle Scholar
  33. 33.
    Steinman, R. M., Cohn, Z. A.: Identification of a novel cell type in peripheral lymphoid organs of mice. I Morphology, quantitation, tissue distribution. J. Exp. Med. 137 ,1142 (1973).PubMedCrossRefGoogle Scholar
  34. 34.
    Steinman, R. M., Lustig, D. S., Cohn, Z. A.: Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vivo. L. Exp. Med. 139 ,1431 (1974).CrossRefGoogle Scholar
  35. 35.
    Steinman, R. M., Adams, J. C., Cohn, Z. A.: Identification of a novel cell type in peripheral lymphoid organs of mice. III. Identification and distribution in mouse spleen. J. Exp. Med. 141 ,804 (1975).PubMedGoogle Scholar
  36. 36.
    Taylor, C, R., Burns, J.: The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody. J. Clin. Pathol. 27,14(1974).PubMedCrossRefGoogle Scholar
  37. 37.
    Van Furth, R., Cohn, Z. A., Hirsch, J. G., Humphrey, J. H., Spector, W., Langevoort, H. L.: The mononuclear phagocyte system: a new classification of macrophages, monocytes and their precursor cells. Bull. W.H.O. 46 ,845 (1972).PubMedGoogle Scholar
  38. 38.
    Wybran, J., Can, M. C., Fudenberg. H. H.: The human rosette forming cells as a marker of a population of thymus derived cells. J. Clin. Invest. 51 ,2537 (1972).PubMedCrossRefGoogle Scholar
  39. 39.
    Yam, L. T., Tavassoli, M., Jacobs, P.: Differential characterization of the “reticulum cell” in lymphoreticular neoplasms. Am. J. Clin. Pathol. 64 ,171 (1975).PubMedGoogle Scholar
  40. 40.
    Ziegler, J. L.: Treatment result of 54 American patients with Burkitt’s lymphoma are similar to the African experience. N. Engl. J. Med. 297 ,75 (1977).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • G. Mathé

There are no affiliations available

Personalised recommendations